Literature DB >> 10548356

Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.

C Blandizzi1, G Natale, G Gherardi, G Lazzeri, C Marveggio, R Colucci, D Carignani, M Del Tacca.   

Abstract

The protective effects of the proton pump inhibitor lansoprazole on gastric mucosal damage induced by ethanol-HCl or hemorrhagic shock were investigated in the present study. The morphometric analysis of gastric histological sections revealed that lansoprazole dose-dependently reduced mucosal injury evoked by ethanol-HCl (ED50 = 24.3 micromol/kg) or hemorrhagic shock (ED50 = 38.9 micromol/kg), these effects being associated with marked increments of Alcian blue recovery from gastric bound mucus (ED50 = 31.4 micromol/kg and 27.6 micromol/kg, respectively). In addition, lansoprazole inhibited gastric acid secretion from pylorus-ligated rats (ED50 = 9.8 micromol/kg). Further experiments, performed on rats with ethanol-HCl-induced gastric injury, indicated that the protective effects of lansoprazole were not modified by L-365,260, suramin, N(G)-nitro-L-arginine, or systemic ablation of capsaicin-sensitive sensory nerves, whereas they were partly blocked by indomethacin and fully prevented by N-ethyl-maleimide. In addition, lansoprazole did not modify somatostatin concentrations in gastric mucosa. The present results provide evidence that lansoprazole prevents the necrotic damage of gastric mucosa induced by ethanol-HCl or hemorrhagic shock. According to the rank order of ED50 values, these effects appear to depend mainly on the enhancement of the gastric mucus barrier rather than on the reduction of acid secretion. It is also proposed that an increased production of prostaglandins, as well as an increased availability of sulfhydryl compounds at level of gastric mucosa may account for the gastroprotective effects of lansoprazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548356     DOI: 10.1023/a:1026626519534

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

Review 1.  Stress ulcers.

Authors:  U Haglund
Journal:  Scand J Gastroenterol Suppl       Date:  1990

2.  Dual effects of N-ethylmaleimide on ethanol-induced gastric lesions in rats.

Authors:  K Takeuchi; M Okada; H Niida; S Okabe
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 3.  Peptic ulcer pathophysiology: acid, bicarbonate, and mucosal function.

Authors:  L Højgaard; A Mertz Nielsen; S J Rune
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 4.  Recent research on the biological activity of suramin.

Authors:  T E Voogd; E L Vansterkenburg; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1993-06       Impact factor: 25.468

5.  Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.

Authors:  H Matsukura; M Masuda; K Kawaguchi; A Uchida; T Kamishiro
Journal:  Jpn J Pharmacol       Date:  1994-05

6.  Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.

Authors:  T Fukuda; T Arakawa; Y Shimizu; K Ohtani; K Higuchi; K Kobayashi
Journal:  J Clin Gastroenterol       Date:  1995       Impact factor: 3.062

7.  Effects of omeprazole on gastric mucosal microcirculation and acid secretion in the rat.

Authors:  L Holm-Rutili
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

8.  Morphology of rat gastric mucosal damage, defense, and restitution in the presence of luminal ethanol.

Authors:  S Ito; E R Lacy
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

9.  Effect of omeprazole on eicosanoid formation in and release from guinea-pig gastric mucosal cells.

Authors:  M Hell; K F Sewing
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

10.  Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach.

Authors:  M R Alison; R Chinery; R Poulsom; P Ashwood; J M Longcroft; N A Wright
Journal:  J Pathol       Date:  1995-04       Impact factor: 7.996

View more
  14 in total

1.  Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Gianfranco Natale; Valter Lubrano; Cristina Vassalle; Luca Antonioli; Gloria Lazzeri; Mario Del Tacca
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 2.  Lansoprazole: an update of its place in the management of acid-related disorders.

Authors:  A J Matheson; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells.

Authors:  Shuji Nakagawa; Yuji Arai; Tsunao Kishida; Nobuyuki Hiraoka; Shinji Tsuchida; Hiroaki Inoue; Ryo Sakai; Osam Mazda; Toshikazu Kubo
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Isolation and Characterization of Putative Probiotic Bacterial Strain, Bacillus amyloliquefaciens, from North East Himalayan Soil Based on In Vitro and In Vivo Functional Properties.

Authors:  V I Hairul Islam; N Prakash Babu; P Pandikumar; S Ignacimuthu
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

5.  Protective effect of comaruman, a pectin of cinquefoil Comarum palustre L., on acetic acid-induced colitis in mice.

Authors:  Sergey V Popov; Raisa G Ovodova; Pavel A Markov; Ida R Nikitina; Yury S Ovodov
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

6.  Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice.

Authors:  Sergey V Popov; Pavel A Markov; Ida-R Nikitina; Sergey Petrishev; Vasily Smirnov; Yury S Ovodov
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

7.  Benzimidazole covalent probes and the gastric H(+)/K(+)-ATPase as a model system for protein labeling in a copper-free setting.

Authors:  Chelsea J Paresi; Qi Liu; Yue-Ming Li
Journal:  Mol Biosyst       Date:  2016-05

8.  Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction.

Authors:  Stephanie Schulz-Geske; Kati Erdmann; Ronald J Wong; David K Stevenson; Henning Schröder; Nina Grosser
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 9.  Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.

Authors:  Ramalinga R Kedika; Rhonda F Souza; Stuart Jon Spechler
Journal:  Dig Dis Sci       Date:  2009-11       Impact factor: 3.199

10.  Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin.

Authors:  O Pastoris; M Verri; F Boschi; O Kastsiuchenka; B Balestra; F Pace; M Tonini; G Natale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.